This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Underpowered Repetitive Transcranial Magnetic Stimulation Might Not Be an Effective Antidepressant Treatment

George Kirov, PhD, MRCPsych; John Tredget, BSc; Emma Dunn, BSc; Valentina Moskvina, PHD; Roger Beer, MRCPsych; and Najeeb Khalid, MCPS, MD

Published: April 15, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 snetences of the full text.

Sir: Koerselman et al.1 reported the results of a trial of repetitivetranscranial magnetic stimulation (rTMS) for the treatmentof depressive disorders. After 2 weeks, the improvementon the 17-item Hamilton Rating Scale for Depression (HAM-D)was not different between the active and the placebo arms of thestudy and in fact was very disappointing at 18.5% and 15.4%,respectively.

We agree with the authors that one explanation for the pooroutcome was the low setting of the stimulation parameters, especiallythe use of just 80% of motor threshold.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...